Home > Balance Sheet > PIRAMAL PHARMA

PIRAMAL PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹-145 Cr₹-157 Cr₹-130 Cr₹-105 Cr₹-22 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of PIRAMAL PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of PIRAMAL PHARMA is ₹-145 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹-145 Cr
Mar2024₹-157 Cr
Mar2023₹-130 Cr
Mar2022₹-105 Cr
Mar2021₹-22 Cr

How is Deferred Tax Assets / Liabilities of PIRAMAL PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹-145 Cr
Negative
Mar2024 ₹-157 Cr
Negative
Mar2023 ₹-130 Cr
Negative
Mar2022 ₹-105 Cr
Negative
Mar2021 ₹-22 Cr -

Compare Deferred Tax Assets / Liabilities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹21,685.9 Cr 3.6% -2.2% -29.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,402.0 Cr 0.5% -1.5% -2.6% Stock Analytics
DIVIS LABORATORIES ₹164,277.0 Cr 5.5% -0.2% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,140.0 Cr 2.1% 2.8% 30.9% Stock Analytics
CIPLA ₹107,398.0 Cr 1.3% -7.9% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,378.0 Cr 2% 4.5% 2.3% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

3.6%

-2.2%

-29.1%

SENSEX

0.4%

-0.2%

6.9%


You may also like the below Video Courses